NCT06208657 2026-01-28
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Australian & New Zealand Children's Haematology/Oncology Group
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT00003245 2018-11-15
Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00718757 2013-08-28
Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies
St. Jude Children's Research Hospital
Phase 1 Completed
NCT00005626 2012-09-25
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT00276003 2010-01-07
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
University of New Mexico
Phase 2 Completed
NCT00222443 2008-09-22
Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy
University of Oklahoma
Phase 1 Completed